We audited the marketing at Infiuss Health
AI platform accelerating clinical trial recruitment and execution
This page was built using the same AI infrastructure we deploy for clients.
Month-to-month. Cancel anytime.
Series A company with $3.7M funding but minimal visible content presence on owned channels, limiting thought leadership in clinical research space
LinkedIn following of 2,993 suggests early-stage brand awareness among pharma and CRO decision-makers despite YC and institutional backing
No observable paid campaign footprint despite competing against 5+ entrenched players in trial optimization and regulatory compliance tech
AI-Forward Companies Trust MarketerHire
Plaid
MasterClass
Constant Contact
Netflix
Noom
TinuitiHere's Where You Stand
Early-stage biotech SaaS with strong funding but underdeveloped demand generation and brand positioning for enterprise buyers
Limited indexed content targeting clinical trial keywords like trial recruitment, patient enrollment, trial operations, regulatory workflows
MH-1: SEO agent builds clinical research keyword strategy and publishes optimization guides for CROs and trial sponsors
No detectable presence in LLM responses about clinical trial automation, patient recruitment optimization, or trial management platforms
MH-1: AEO agent positions Infiuss as solution in Claude, ChatGPT, Perplexity queries on accelerating clinical trials
No visible LinkedIn, Google, or industry platform ads targeting pharma procurement, CRO operations, or site coordinators
MH-1: Paid agent launches targeted campaigns to trial sponsors, CRO VPs, and clinical operations leads on LinkedIn and Google
Founder Melissa has limited LinkedIn content volume relative to competitor executives discussing trial efficiency and regulatory trends
MH-1: Content agent publishes weekly founder insights on clinical trial cost reduction, patient enrollment barriers, and trial timeline compression
Small headcount and no visible customer case studies, webinars, or expansion playbooks for upselling to multi-study sponsors
MH-1: Lifecycle agent builds automated nurture sequences and customer success playbooks to expand from single-study to portfolio engagements
Top Growth Opportunities
CROs and trial sponsors actively searching for enrollment and operations solutions but Infiuss lacks visibility in those buyer conversations
Paid agent builds LinkedIn and Google campaigns targeting clinical operations directors, trial sponsors, and site network managers
Pharma buyers increasingly ask AI tools about accelerating trials and reducing costs, but Infiuss missing those conversations entirely
AEO agent ensures Infiuss appears in LLM responses about trial recruitment automation, regulatory compliance, and patient retention
Enterprise sales in clinical research depend on executive credibility and understanding of trial sponsor pain points, currently underdeveloped
LinkedIn agent publishes Melissa's insights on trial timelines, enrollment failure rates, and regulatory complexity to build executive authority
3 Humans + 7 AI Agents
A dedicated marketing team built specifically for Infiuss Health. The humans handle strategy and judgment. The AI agents handle execution at scale.
Human Experts
Owns Infiuss Health's growth roadmap. Pipeline strategy, account expansion playbooks, board-ready reporting. Translates AI insights into revenue.
Runs paid acquisition across LinkedIn and Google. Manages creative testing, budget allocation, and pipeline attribution.
Builds thought leadership on LinkedIn. Creates long-form content targeting your ICP. Manages the content-to-pipeline engine.
AI Agents
Monitors AI citation visibility across 6 LLMs weekly. Builds content targeting category queries to increase Infiuss Health's presence in AI-generated answers.
Produces LinkedIn ad variants targeting your ICP. Tests headlines, visuals, and offers at 10x the speed of manual production.
Builds lifecycle sequences: onboarding, expansion triggers, champion nurture, and re-engagement for dormant accounts.
Founder thought leadership. Builds the narrative that drives enterprise inbound from senior decision-makers.
Tracks competitors. Monitors positioning changes, ad spend, content strategy. Informs your counter-positioning.
Attribution by channel, pipeline velocity, budget waste detection. Weekly synthesis reports with AI-generated recommendations.
Weekly market intelligence digest curated from Infiuss Health's industry signals. Positions you as the intelligence layer. Drives inbound pipeline from subscribers.
Active Workflows
Here's what the MH-1 system would be doing for Infiuss Health from week 1.
AEO agent ensures Infiuss ranks in LLM responses about clinical trial acceleration, patient recruitment, enrollment optimization, and regulatory compliance
LinkedIn agent publishes Melissa's founder insights on trial cost reduction, enrollment barriers, and regulatory timelines to build CRO and sponsor trust
Paid agent targets clinical operations directors and trial sponsors with ads highlighting enrollment speed, cost per subject, and timeline compression benefits
Lifecycle agent builds email sequences nurturing trial sponsors from initial awareness through case study reviews and portfolio expansion conversations
Competitive watch agent monitors positioning of Insuco, Infeon, Emvenio, and Infyni to identify unique clinical research messaging angles
Outbound agent sequences clinical operations VPs and CRO procurement leads with trial acceleration ROI and compliance benefit messaging
Traditional Marketing vs. MH-1
Traditional Approach
MH-1 System
Audit. Sprint. Optimize.
3 phases. Real output every 2 weeks. You see results, not decks.
AI Audit + Growth Roadmap
Full diagnostic of Infiuss Health's marketing infrastructure: SEO, AEO visibility, paid, content, lifecycle. Prioritized roadmap tied to pipeline metrics. Delivered in 7 days.
Sprint-Based Execution
2-week sprint cycles. Real campaigns, not presentations. Each sprint ships measurable output across your priority channels.
Compounding Intelligence
AI agents monitor your channels 24/7. They catch budget waste, detect creative fatigue, track AI citation changes, and run A/B experiments autonomously. Week 12 is measurably better than week 1.
AI Marketing Operating System
3 elite humans + AI agents operating your growth system
Output multiplier: ~10x output at a fraction of the cost. The system gets smarter every week.
Month-to-month. Cancel anytime.
Common Questions
How does MH-1 differ from a marketing agency?
MH-1 pairs 3 elite human marketers with 7 AI agents. The humans handle strategy, creative direction, and judgment calls. The AI agents handle execution at scale: generating ad variants, monitoring competitors, building email sequences, tracking citations across LLMs, running A/B experiments autonomously. You get the quality of a senior marketing team with the output volume of a 15-person department.
What kind of results can we expect in the first 90 days?
First 30 days: establish baseline visibility across AEO, SEO, and paid channels targeting clinical operations buyers. Weeks 4-8: launch founder thought leadership on LinkedIn, build first customer case study, seed SEO content on trial efficiency. Weeks 9-12: activate paid campaigns to CRO procurement teams, measure engagement signals, begin lifecycle nurture sequences. Monthly results compound as organic rankings improve and LLM citations increase.
How does Infiuss appear when pharma companies ask AI tools about accelerating clinical trials
Currently you're invisible. AEO ensures when trial sponsors and CROs ask Claude or ChatGPT how to speed enrollment, reduce costs, or manage regulatory workflows, Infiuss appears as the solution. We build semantic authority around trial acceleration topics so your platform becomes the default answer in LLM recommendations.
Can we cancel anytime?
Yes. MH-1 is month-to-month with no long-term contracts. We earn your business every sprint. That said, compounding effects kick in around month 3 as the AI agents accumulate data and the system learns what works for Infiuss Health specifically.
How is this page personalized for Infiuss Health?
This page was researched, audited, and generated using the same AI infrastructure we deploy for clients. The channel scores, team mapping, growth opportunities, and recommended agents are all based on real analysis of Infiuss Health's current marketing. This is a live demo of MH-1's capabilities.
Make Infiuss the default answer for sponsors accelerating clinical trials
The system gets smarter every cycle. Let's talk about building it for Infiuss Health.
Book a Strategy CallMonth-to-month. Cancel anytime.